Artificial Intelligence | Machine Learning Theseus Pharmaceuticals | Outsmarting Cancer Resistance


Enterprise, Biotechnology, Health Care, Pharmaceuticals, Drug Discovery, Cancer Treatment Cambridge, MA, United States

Theseus Pharmaceuticals

Artificial Intelligence | Machine Learning


Theseus Pharmaceuticals | Outsmarting Cancer Resistance

Theseus Pharmaceuticals

Biotechnology, Health Care, Pharmaceuticals, Drug Discovery, Cancer Treatment


Cambridge, MA, United States

Our oncology therapies are specifically designed to overcome treatment-resistant cancer mutations. Theseus Pharmaceuticals is passionately committed to outsmarting cancer resistance. Cancer is constantly mutating, allowing it to evade initially effective oncology treatments. Theseus believes we can predict how cancer will change, enabling new therapies to stay ahead of future mutations and overcome the demonstrated burden of treatment resistance.

Led by a team of pioneers in the discovery and development of tyrosine kinase inhibitors (TKIs), we are developing best-in-class, pan-variant kinase inhibitors, to shape the future of targeted oncology. As tumor mutations arise during treatment, current-generation TKIs become ineffective. With predictive assays and a pan-variant strategy, Theseus can anticipate why treatments fail. Empowered by this knowledge, we aim to design TKIs that target known mutations, and prevent the emergence of new ones.

 

B2B

1 to 25

Series B

$105 M

Scaling Up

2017

 
 

Pharmaceuticals
Healthcare
Biotechnology

N/A

N/A

 
 

Service

Yes

Active

 
 

   Machine Learning


Biotechnology

Biotechnology

Health Care

Health Care

Drug Discovery

Drug Discovery


N/A

 

   Software


N/A


Machine Learning Algorithm

Machine Learning Algorithm

 
 

View All

Senior Director, Clinical Operations

Cambridge, Massachusetts

Director, DMPK

Cambridge, Massachusetts

Director, Discovery Biology

Cambridge, Massachusetts

Director, Computational Chemistry

Cambridge, Massachusetts

 

AI/ML Professionals

Want to work at Theseus Pharmaceuticals?

We can introduce you to the right person at Theseus Pharmaceuticals

Talk to our Talent Team

 

10

1

$100M

Company was founded 2017 and it took almost 4 years (Apr 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

04/13/2021

Series B

$100M

T. Rowe Price, Rock Springs Capital, Pontifax, OrbiMed, Omega Healthcare Investors, Nextech Invest, Longitude Capital, Foresite Capital, Farallon Capital Management, Adage Capital Management

Date : 04/13/2021

Round: Series B

$ Raised: $100M

Investors: T. Rowe Price, Rock Springs Capital, Pontifax, OrbiMed, Omega Healthcare Investors, Nextech Invest, Longitude Capital, Foresite Capital, Farallon Capital Management, Adage Capital Management

 

Investors

Interested in researching Theseus Pharmaceuticals?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Theseus Pharmaceuticals

Request a Demo - Deal Souring Platform

 
Tim Clackson


Tim Clackson
President and CEO

David Kerstein


David Kerstein
Chief Medical Officer

David Dalgarno


David Dalgarno
Founder, Chief Technical Officer

Victor Rivera


Victor Rivera
Founder, Senior Vice President, Chief Scientific Officer

William C. Shakespeare


William C. Shakespeare
Founder, President Research & Development

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Theseus Pharmaceuticals